Recent computational studies have identified the cyclic peptide PYRRP as a promising dengue fusion inhibitor, demonstrating strong binding and stability with DENV envelope protein in molecular docking and dynamics simulation, highlighting its potential as a novel antiviral candidate [20]. The gene discussed is ERVW-1; the disease is dengue disease.